Search results
Viking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEO - Viking Therapeutics...
Benzinga· 18 hours agoViking Therapeutics, Inc. VKTX reported its first-quarter financial results after the bell...
3 Millionaire-Maker Biotech Stocks
Motley Fool via Yahoo Finance· 48 minutes agoThat's nearly twice the stock's present price. 3. Viking Therapeutics Last but not least, add Viking Therapeutics (NASDAQ: VKTX) to your list of...
Viking Therapeutics, Inc. (VKTX) Q1 2024 Earnings Call Transcript
Seeking Alpha· 15 hours agoViking Therapeutics, Inc. (NASDAQ:NASDAQ:VKTX) Q1 2024 EarninConference Call April 24, 2024 8:30 AM ETCompany ParticipantsStephanie Diaz - Manager, Investor...
Viking Therapeutics down 4% despite quarterly bottom line beat
Seeking Alpha· 17 hours agoShares of Viking Therapeutics decline despite beating bottom-line expectations in Q1 2024. Read more...
Wetzel Investment Advisors Inc. Makes New Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)
ETF DAILY NEWS· 3 days ago(NASDAQ:VKTX – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor ...
Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX
Invezz· 4 days agoJohnson & Johnson is acquiring Shockwave Medical while Novo Nordisk is buying Catalent, a CDMO...
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 2.2%
ETF DAILY NEWS· 4 days agoViking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report)’s stock price traded down 2.2% during trading on Friday . The company traded as low as $62.65 ...
Viking Therapeutics Inc (VKTX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
GuruFocus.com via Yahoo Finance· 8 hours agoPublic Offering: Raised approximately $630 million in gross proceeds from a public offering of common stock. Release Date: April 24, 2024 For the complete transcript of the ...
Viking Therapeutics, Inc. (VKTX) Suffers a Larger Drop Than the General Market: Key Insights
Zacks via Yahoo Finance· 6 days agoViking Therapeutics, Inc. (VKTX) ended the recent trading session at $63.42, demonstrating a -1.93%...
Viking (VKTX) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 6 days agoOn average, ARGX witnessed an earnings surprise of 14.18% in the last four quarters. CytomX...
